OtherBASIC SCIENCE INVESTIGATIONS
Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V
Francis G. Blankenberg, Louie Naumovski, Johnathan F. Tait, Anneke M. Post and H. William Strauss
Journal of Nuclear Medicine February 2001, 42 (2) 309-316;
Francis G. Blankenberg
Louie Naumovski
Johnathan F. Tait
Anneke M. Post
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Imaging Cyclophosphamide-Induced Intramedullary Apoptosis in Rats Using 99mTc-Radiolabeled Annexin V
Francis G. Blankenberg, Louie Naumovski, Johnathan F. Tait, Anneke M. Post, H. William Strauss
Journal of Nuclear Medicine Feb 2001, 42 (2) 309-316;
Related Articles
- No related articles found.
Cited By...
- Annexin A5-Conjugated Polymeric Micelles for Dual SPECT and Optical Detection of Apoptosis
- Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease
- Enhanced Apoptotic Reaction Correlates with Suppressed Tumor Glucose Utilization After Cytotoxic Chemotherapy: Use of 99mTc-Annexin V, 18F-FDG, and Histologic Evaluation
- Evaluation of 18F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis
- Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model
- Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V
- Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate
- Imaging Apoptosis with 99mTc-Annexin-V in Experimental Subacute Myocarditis
- Near-Infrared Fluorescent Imaging of Tumor Apoptosis
- Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V
- Imaging Apoptosis in Rheumatoid Arthritis
- Increased Uptake of the Apoptosis-imaging Agent 99mTc Recombinant Human Annexin V in Human Tumors after One Course of Chemotherapy as a Predictor of Tumor Response and Patient Prognosis